receptor concentration
Recently Published Documents


TOTAL DOCUMENTS

282
(FIVE YEARS 7)

H-INDEX

39
(FIVE YEARS 2)

2020 ◽  
Vol 2020 ◽  
pp. 1-9
Author(s):  
Daisuke Watanabe ◽  
Satoshi Morimoto ◽  
Noriko Morishima ◽  
Yoichiro Kato ◽  
Yoji Nagashima ◽  
...  

The (pro)renin receptor [(P)RR] is a multifunctioning protein playing roles in various pathological conditions. A soluble form of (P)RR [s(P)RR] has been considered a biomarker for (P)RR expression in tissues. Expression of (P)RR has been described in aldosterone-producing adenoma (APA), but the roles of (P)RR have yet to be fully determined. This study investigated the significance of (P)RR and serum s(P)RR concentrations in patients with APA. We evaluated associations between (P)RR expression and expression of CYP11B2, an aldosterone synthase, and aldosterone production by the adrenal glands and assessed the relationships between serum s(P)RR concentration and background factors. (P)RR colocalized with CYP11B2 and expression levels of (P)RR were positively associated with those of CYP11B2 in APA tissues. (P)RR immunoreactivity in these tissues correlated positively with plasma aldosterone concentrations (PAC) and urinary aldosterone excretion. Also, in APA, (P)RR mRNA abundance was positively correlated with β-catenin mRNA abundance. Significant positive correlations were identified between serum s(P)RR concentration and plasma glucose, hemoglobin A1c, and serum creatinine levels, but not with PAC (in either peripheral vein or adrenal vein) or adrenal (P)RR expression level. This study showed that (P)RR expression level correlates with CYP11B2 expression in APA tissues and PAC and urinary aldosterone excretion, suggesting that (P)RR expression may contribute to aldosterone synthesis via CYP11B2 activation in APAs, although serum s(P)RR concentration failed to show any significant relationship with adrenal (P)RR expression. Adrenal (P)RR activity might offer a therapeutic target in the treatment of PA, although this issue needs to be investigated in future studies.


2020 ◽  
Vol 21 (1) ◽  
pp. 92-98 ◽  
Author(s):  
Gustavo Vizcardo-Galindo ◽  
Fabiola León-Velarde ◽  
Francisco C. Villafuerte

Pain ◽  
2020 ◽  
Vol 161 (1) ◽  
pp. 74-82 ◽  
Author(s):  
Florence B. Pomares ◽  
Steve Roy ◽  
Thomas Funck ◽  
Natasha A. Feier ◽  
Alexander Thiel ◽  
...  

2019 ◽  
Vol 42 (12) ◽  
pp. 1951-1960 ◽  
Author(s):  
Kaoru Yamashita ◽  
Satoshi Morimoto ◽  
Yasufumi Seki ◽  
Daisuke Watanabe ◽  
Atsuhiro Ichihara

2019 ◽  
Author(s):  
Michael R. Stoneman ◽  
Gabriel Biener ◽  
Richard J. Ward ◽  
John D. Pediani ◽  
Dammar Badu ◽  
...  

Abstract Current methods for determining membrane protein association in cells are either very time consuming, require complicated procedures, or lack the sensitivity needed to assess the effect of concentration or ligand binding on the observed oligomerization. To overcome these limitations, we provide a detailed protocol for quantifying the relative abundance and stability of oligomers of differing sizes using two-dimensional fluorescence intensity fluctuation (2D-FIF) spectrometry. The approach can be implemented using a standard laser scanning fluorescence microscope along with custom written software for image analysis. This method may be applied to evaluate the extent of oligomerization as a function of receptor concentration and is particularly suited to assess the effects of agonists and antagonists on the oligomeric size of membrane receptors of interest.


Author(s):  
Takuya Shimura ◽  
Makoto Kurano ◽  
Yoshifumi Morita ◽  
Naoyuki Yoshikawa ◽  
Masako Nishikawa ◽  
...  

Background Invasion of the central nervous system by haematological malignancies is diagnosed by cytological analyses of cerebrospinal fluid or diagnostic imaging, while quantitative biomarkers for central nervous system invasion are not available and needed to be developed. Methods In this study, we measured the concentrations of autotaxin and soluble IL-2 receptor in cerebrospinal fluid and evaluated their usefulness as biomarkers for central nervous system invasion. Results We observed that both the autotaxin and soluble IL-2 receptor concentrations in cerebrospinal fluid were higher in subjects with central nervous system invasion than in those without, and the cerebrospinal fluid concentrations were independent from the serum concentrations of these biomarkers. ROC analyses revealed that the soluble IL-2 receptor concentration in cerebrospinal fluid was a strong discriminator of central nervous system invasion in subjects with haematological malignancies, while the autotaxin concentration in cerebrospinal fluid also had a strong ability to discriminate central nervous system invasion when the subjects were limited to those with lymphoma. The combined measurement of autotaxin and soluble IL-2 receptor in cerebrospinal fluid improved the sensitivity without notably reducing the specificity for central nervous system invasion in subjects with lymphoma when central nervous system invasion was diagnosed in cases where either value was beyond the respective cut-off value. Conclusion These results suggest the possible usefulness of soluble IL-2 receptor and autotaxin concentrations in cerebrospinal fluid for the diagnosis of central nervous system invasion.


2018 ◽  
Vol 92 ◽  
pp. 93-103 ◽  
Author(s):  
Daniel L. Egbenya ◽  
Suleman Hussain ◽  
Yi-Chen Lai ◽  
Jun Xia ◽  
Anne E. Anderson ◽  
...  

2018 ◽  
Vol 36 ◽  
pp. e141
Author(s):  
Satoshi Morimoto ◽  
Kaoru Yamashita ◽  
Shihori Kimura ◽  
Noriyoshi Takano ◽  
Yasufumi Seki ◽  
...  

2018 ◽  
Vol 69 (8) ◽  
pp. 2251-2253
Author(s):  
Paul Salahoru ◽  
Cristina Mihaela Ghiciuc ◽  
Cristina Grigorescu ◽  
Marius Valeriu Hinganu ◽  
Catalina Elena Lupusoru

Myasthenia gravis is an autoimmune disorder which presents a series of clinical manifestations which are generally motor. The hallmark of the disorder is muscle weakness, which typically worsens during physical exercise and improves upon rest. Approximatively 80% of the patients presenting this affection test positive for Acetylcholine antibody anti-receptor (AChR-ab).Treatment of patients with myasthenia gravis consists of:administration of oral medica-tion, immunomodulating treatment by removal of AChR-ab through plasmapheresis or surgical intervention (thymectomy).This article presents a retrospective study in which the authors attempted to identify factors which can influence the effect of thymectomy on AChR-ab titration and on the clinical presentation of the patients suffering with myasthenia gravis.


Sign in / Sign up

Export Citation Format

Share Document